Feature Papers to Celebrate the Inaugural Issue of Journal of Pharmaceutical and BioTech Industry

The launch of the Journal of Pharmaceutical and BioTech Industry (JPBI) marks a vital step in creating a forum for sharing high-quality pharmaceutical and biotechnology research. To celebrate its first issue, Feature Papers will bring contributions showing breadth, scientific excellence and translational potential of connected fields. Pharmacy and biotechnology are being transformed by new stakeholders, artificial intelligence and sustainability. Both impact small molecule drug discovery, biologics, precision medicine, advanced manufacturing and production. New therapeutic modalities-peptides, oligonucleotides, monoclonal antibodies, antibody-drug conjugates, gene and cell therapies and innovative drug-delivery systems-are reshaping common and rare disease treatment. Converting these advances into safe and affordable medicines requires collaboration among academia, industry, healthcare professionals, regulatory authorities and policymakers. This collection welcomes original research, reviews, perspectives and case studies covering the pharmaceutical and biotechnology value chain, from discovery and process development to manufacturing, quality control, regulation, clinical translation and commercialization. Attention is paid to new technologies, sustainable practices and strategies improving pharmaceutical production efficiency and resilience.